Original language | English (US) |
---|---|
Pages (from-to) | 1395-1397 |
Number of pages | 3 |
Journal | JAMA Oncology |
Volume | 7 |
Issue number | 9 |
DOIs | |
State | Published - Sep 2021 |
ASJC Scopus subject areas
- Oncology
- Cancer Research
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: JAMA Oncology, Vol. 7, No. 9, 09.2021, p. 1395-1397.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Incidence of Axillary Adenopathy in Breast Imaging after COVID-19 Vaccination
AU - Robinson, Kristin A.
AU - Maimone, Santo
AU - Gococo-Benore, Denise A.
AU - Li, Zhuo
AU - Advani, Pooja P.
AU - Chumsri, Saranya
N1 - Funding Information: Funding/Support: This project was made possible by the Yale National Clinician Scholars Program and by Clinical and Translational Science Awards grant TL1 TR001864 from the National Center for Advancing Translational Science, a component of the National Institutes of Health (NIH). Funding Information: Author Contributions: Dr Chumsri had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: Robinson, Maimone, Advani, Chumsri. Acquisition, analysis, or interpretation of data: All authors. Drafting of the manuscript: Robinson, Maimone, Advani, Chumsri. Critical revision of the manuscript for important intellectual content: All authors. Statistical analysis: Maimone, Li, Advani, Chumsri. Obtained funding: Chumsri. Administrative, technical, or material support: Chumsri. Supervision: Maimone, Chumsri. Conflict of Interest Disclosures: Dr Advani reported grants from Genentech during the conduct of the study. Dr Chumsri reported grants from Pfizer during the conduct of the study; grants from Merck & Co, the Department of Defense, and the Breast Cancer Research Foundaiton; and personal fees from Novartis, Immunomedics, Puma Biotechnology, BioTheranostics, AstraZeneca, Eisai, Athenex, and Daiichi Sankyo outside the submitted work. No other disclosures were reported. Funding/Support: Research reported in this publication was supported by Mayo Clinic.
PY - 2021/9
Y1 - 2021/9
UR - http://www.scopus.com/inward/record.url?scp=85111356930&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85111356930&partnerID=8YFLogxK
U2 - 10.1001/jamaoncol.2021.3127
DO - 10.1001/jamaoncol.2021.3127
M3 - Letter
C2 - 34292295
AN - SCOPUS:85111356930
SN - 2374-2437
VL - 7
SP - 1395
EP - 1397
JO - JAMA Oncology
JF - JAMA Oncology
IS - 9
ER -